IDEAYA Biosciences, Inc. (IDYA) stock
IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/307% below fair value
$27.40−2.96 (-9.75%)
Close on Nov 17, 2026Market cap $2.64BP/E –Yield –
IDEAYA Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
IDEAYA Biosciences's price to book ratio was 2.6× on Nov 11, 2026, against 2.9× a year earlier. Over the last 5 years it ranged from 1.2× to 5.0×, with a median of 2.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.6× | −0.1 |
| 2025 | Dec 31, 2025 | 2.8× | +0.9 |
| 2024 | Dec 31, 2024 | 1.9× | −2.2 |
| 2023 | Dec 29, 2023 | 4.1× | +1.7 |
| 2022 | Dec 30, 2022 | 2.4× | −0.5 |
| 2021 | Dec 31, 2021 | 2.9× | +0.8 |
| 2020 | Dec 31, 2020 | 2.1× | +0.7 |
| 2019 | Dec 31, 2019 | 1.4× | – |
See a number that looks wrong?